Electrocardiogram (EKG/ECG): What It Shows and What to Expect

An electrocardiogram — recorded as either EKG (from the German Elektrokardiogramm) or ECG — is a non-invasive electrical recording of the heart's activity and one of the most widely ordered diagnostic tests in cardiovascular medicine. The test captures the timing and magnitude of electrical impulses that coordinate each heartbeat, producing a waveform trace that trained clinicians interpret for signs of arrhythmia, ischemia, structural abnormality, and conduction disease. Understanding what the test measures, how it is performed, and when it is ordered helps patients and referring clinicians navigate cardiology evaluations found across resources like Cardiology Authority.

Definition and Scope

An EKG records voltage differences across the body surface that correspond to depolarization and repolarization of heart muscle cells. The standard 12-lead EKG — the most commonly performed format — uses 10 electrodes placed on the limbs and chest to generate 12 distinct electrical views of the heart. According to the American Heart Association's clinical guidance on electrocardiography, these 12 leads provide spatial information across the inferior, lateral, anterior, and septal walls of the myocardium.

The resulting tracing is divided into named waveform components:

P wave — atrial depolarization (the upper chambers contracting)
PR interval — conduction time from atria through the atrioventricular (AV) node
QRS complex — ventricular depolarization (the lower chambers contracting)
ST segment — early ventricular repolarization; the clinically critical zone for ischemia detection
T wave — ventricular repolarization
QT interval — total ventricular electrical activity duration; prolongation above 500 milliseconds is associated with elevated arrhythmia risk (ACC/AHA guidelines on QT prolongation)

Beyond the standard 12-lead format, two other configurations are in routine clinical use:

15-lead and 18-lead EKGs add posterior and right-sided leads (V7–V9 and V3R–V4R) to detect right ventricular and posterior myocardial infarctions that a standard 12-lead may miss.
Single-lead rhythm strips — used in continuous bedside monitoring and wearable devices — sacrifice spatial breadth for extended temporal coverage.

The regulatory context for cardiology establishes that EKG equipment used in clinical settings falls under FDA oversight as a Class II medical device under 21 CFR Part 870, with performance standards applicable to both the hardware and the software-based interpretation algorithms now embedded in modern EKG machines.

How It Works

Electrode placement follows standardized anatomical landmarks defined by the American Heart Association and the Heart Rhythm Society. Limb leads (I, II, III, aVR, aVL, aVF) require electrodes on both wrists and both ankles. Precordial leads (V1–V6) are placed across the left chest, beginning at the fourth intercostal space at the right sternal border and progressing laterally.

The machine amplifies microvolt-level signals, filters artifact, and plots voltage against time — typically at a paper speed of 25 mm/second and a gain of 10 mm/mV. These calibration defaults are standardized across most clinical environments to allow consistent cross-institutional comparison.

A resting 12-lead EKG captures roughly 10 seconds of cardiac electrical activity. During those 10 seconds, the machine samples the rhythm at a rate sufficient to identify beat-to-beat variability, rate, and morphology. Automated interpretation algorithms generate a preliminary read, but the American College of Cardiology and American Heart Association clinical standards require physician over-read for all diagnostic EKGs — automated algorithms alone carry false-positive rates that vary by condition but can exceed 10% for specific diagnoses such as left ventricular hypertrophy.

No radiation, injected contrast, or sedation is involved. The procedure typically takes 5 to 10 minutes from electrode placement to printed tracing.

Common Scenarios

EKGs are ordered across a broad range of clinical situations. The most frequent indications include:

Chest pain evaluation — the EKG is the first-line tool for differentiating ST-elevation myocardial infarction (STEMI) from non-ST-elevation presentations; a STEMI pattern on EKG triggers a time-sensitive catheterization lab activation protocol, with ACC/AHA guidelines setting a door-to-balloon time target of 90 minutes at percutaneous coronary intervention-capable hospitals (ACC/AHA STEMI Guideline)
Palpitations and arrhythmias — identification of atrial fibrillation, atrial flutter, supraventricular tachycardia, ventricular tachycardia, or bradyarrhythmias
Syncope workup — evaluation for conduction block, long QT syndrome, Brugada pattern, or Wolff-Parkinson-White (WPW) syndrome
Pre-operative screening — required in many surgical protocols for patients over 40 or with known cardiovascular risk factors
Medication monitoring — drugs including antiarrhythmics, antipsychotics, and certain antibiotics carry QT-prolonging effects requiring baseline and follow-up EKG surveillance
Heart failure management — detecting left bundle branch block (LBBB), which affects eligibility for cardiac resynchronization therapy (CRT)
Routine cardiovascular risk screening — though the U.S. Preventive Services Task Force (USPSTF) issued a 2018 recommendation against routine resting EKG screening in low-risk asymptomatic adults, citing insufficient evidence of net benefit

For patients with intermittent symptoms not captured on a resting EKG, a Holter monitor or ambulatory monitoring device extends recording to 24 to 48 hours or longer.

Decision Boundaries

The EKG is a powerful but bounded tool. It records electrical activity only at the moment of the test; a normal resting EKG does not exclude coronary artery disease, structural heart disease, or episodic arrhythmia. A 2017 analysis published in the Journal of the American College of Cardiology found that up to 50% of patients with angiographically confirmed coronary artery disease had a normal resting EKG between events.

EKG versus Echocardiogram: An EKG reveals electrical behavior; an echocardiogram reveals structural and mechanical function — wall motion, valve morphology, ejection fraction, and chamber dimensions. These two tests are complementary, not interchangeable.

EKG versus Stress Testing: A resting EKG captures the heart under basal conditions. A cardiac stress test provokes the heart under physiological demand and may unmask ischemia or arrhythmia invisible at rest.

Key findings that elevate a tracing from incidental to urgent include:

ST-segment elevation ≥ 1 mm in two or more contiguous leads — presumed STEMI until proven otherwise
New left bundle branch block — may represent acute ischemia in the correct clinical context
QTc > 500 ms — elevated risk for torsades de pointes, a potentially fatal ventricular arrhythmia
Complete heart block (third-degree AV block) — absence of coordinated atrioventricular conduction; often requires emergency pacing via a pacemaker
Ventricular tachycardia — QRS rate above 100 bpm with wide-complex morphology; hemodynamically unstable forms require immediate intervention

Artifact mimicry presents an ongoing diagnostic challenge. Tremor artifact can simulate atrial fibrillation; poor electrode contact can simulate ST changes; limb lead reversal, which occurs in an estimated 0.4% to 4% of clinical EKGs (Heart Rhythm Society position paper), can simulate dextrocardia or inferior MI.

References

The law belongs to the people. Georgia v. Public.Resource.Org, 590 U.S. (2020)